Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

1.

Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial.

Leyvraz S, Piperno-Neumann S, Suciu S, Baurain JF, Zdzienicki M, Testori A, Marshall E, Scheulen M, Jouary T, Negrier S, Vermorken JB, Kaempgen E, Durando X, Schadendorf D, Gurunath RK, Keilholz U.

Ann Oncol. 2014 Mar;25(3):742-6. doi: 10.1093/annonc/mdt585. Epub 2014 Feb 7.

PMID:
24510314
[PubMed - in process]
2.

Immunologic response to the survivin-derived multi-epitope vaccine EMD640744 in patients with advanced solid tumors.

Lennerz V, Gross S, Gallerani E, Sessa C, Mach N, Boehm S, Hess D, von Boehmer L, Knuth A, Ochsenbein AF, Gnad-Vogt U, Zieschang J, Forssmann U, Woelfel T, Kaempgen E.

Cancer Immunol Immunother. 2014 Apr;63(4):381-94. doi: 10.1007/s00262-013-1516-5. Epub 2014 Feb 2.

PMID:
24487961
[PubMed - indexed for MEDLINE]
3.

Cell tracking using multimodal imaging.

Srinivas M, Melero I, Kaempgen E, Figdor CG, de Vries IJ.

Contrast Media Mol Imaging. 2013 Nov-Dec;8(6):432-8. doi: 10.1002/cmmi.1561.

PMID:
24375899
[PubMed - in process]
4.

Rare BRAF mutations in melanoma patients: implications for molecular testing in clinical practice.

Heinzerling L, Kühnapfel S, Meckbach D, Baiter M, Kaempgen E, Keikavoussi P, Schuler G, Agaimy A, Bauer J, Hartmann A, Kiesewetter F, Schneider-Stock R.

Br J Cancer. 2013 May 28;108(10):2164-71. doi: 10.1038/bjc.2013.143. Epub 2013 Apr 11.

PMID:
23579220
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Anti-cytotoxic T-cell lymphocyte antigen-4-induced regression of spinal cord metastases in association with renal failure, atypical pneumonia, vision loss, and hearing loss.

Voskens C, Cavallaro A, Erdmann M, Dippel O, Kaempgen E, Schuler G, Schuler-Thurner B, Heinzerling L.

J Clin Oncol. 2012 Nov 20;30(33):e356-7. doi: 10.1200/JCO.2011.41.4359. Epub 2012 Oct 8. No abstract available.

PMID:
23045571
[PubMed - indexed for MEDLINE]
6.

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial.

Hauschild A, Grob JJ, Demidov LV, Jouary T, Gutzmer R, Millward M, Rutkowski P, Blank CU, Miller WH Jr, Kaempgen E, Martín-Algarra S, Karaszewska B, Mauch C, Chiarion-Sileni V, Martin AM, Swann S, Haney P, Mirakhur B, Guckert ME, Goodman V, Chapman PB.

Lancet. 2012 Jul 28;380(9839):358-65. doi: 10.1016/S0140-6736(12)60868-X. Epub 2012 Jun 25.

PMID:
22735384
[PubMed - indexed for MEDLINE]
7.

Human dendritic cells efficiently phagocytose adenoviral oncolysate but require additional stimulation to mature.

Schierer S, Hesse A, Knippertz I, Kaempgen E, Baur AS, Schuler G, Steinkasserer A, Nettelbeck DM.

Int J Cancer. 2012 Apr 1;130(7):1682-94. doi: 10.1002/ijc.26176. Epub 2011 Aug 3.

PMID:
21557217
[PubMed - indexed for MEDLINE]
8.

[Melanoma and pregnancy].

Erfurt-Berge C, Kaempgen E.

Hautarzt. 2010 Dec;61(12):1040-5. doi: 10.1007/s00105-010-2005-9. Review. German.

PMID:
21076805
[PubMed - indexed for MEDLINE]
9.

Performance of serum-supplemented and serum-free media in IFNgamma Elispot Assays for human T cells.

Janetzki S, Price L, Britten CM, van der Burg SH, Caterini J, Currier JR, Ferrari G, Gouttefangeas C, Hayes P, Kaempgen E, Lennerz V, Nihlmark K, Souza V, Hoos A.

Cancer Immunol Immunother. 2010 Apr;59(4):609-18. doi: 10.1007/s00262-009-0788-2. Epub 2009 Nov 6.

PMID:
19894047
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium.

Britten CM, Janetzki S, Ben-Porat L, Clay TM, Kalos M, Maecker H, Odunsi K, Pride M, Old L, Hoos A, Romero P; HLA-peptide Multimer Proficiency Panel of the CVC-CRI Immune Assay Working Group.

Cancer Immunol Immunother. 2009 Oct;58(10):1701-13. doi: 10.1007/s00262-009-0681-z. Epub 2009 Mar 4.

PMID:
19259668
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial.

Eggermont AM, Suciu S, Santinami M, Testori A, Kruit WH, Marsden J, Punt CJ, Salès F, Gore M, Mackie R, Kusic Z, Dummer R, Hauschild A, Musat E, Spatz A, Keilholz U; EORTC Melanoma Group.

Lancet. 2008 Jul 12;372(9633):117-26. doi: 10.1016/S0140-6736(08)61033-8.

PMID:
18620949
[PubMed - indexed for MEDLINE]
12.

Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme.

De Vleeschouwer S, Fieuws S, Rutkowski S, Van Calenbergh F, Van Loon J, Goffin J, Sciot R, Wilms G, Demaerel P, Warmuth-Metz M, Soerensen N, Wolff JE, Wagner S, Kaempgen E, Van Gool SW.

Clin Cancer Res. 2008 May 15;14(10):3098-104. doi: 10.1158/1078-0432.CCR-07-4875.

PMID:
18483377
[PubMed - indexed for MEDLINE]
Free Article
13.

Dendritic cell based antitumor vaccination: impact of functional indoleamine 2,3-dioxygenase expression.

Wobser M, Voigt H, Houben R, Eggert AO, Freiwald M, Kaemmerer U, Kaempgen E, Schrama D, Becker JC.

Cancer Immunol Immunother. 2007 Jul;56(7):1017-24. Epub 2006 Dec 29.

PMID:
17195079
[PubMed - indexed for MEDLINE]
14.

Efficient elutriation of monocytes within a closed system (Elutra) for clinical-scale generation of dendritic cells.

Berger TG, Strasser E, Smith R, Carste C, Schuler-Thurner B, Kaempgen E, Schuler G.

J Immunol Methods. 2005 Mar;298(1-2):61-72. Erratum in: J Immunol Methods. 2005 Aug;303(1-2):152.

PMID:
15847797
[PubMed - indexed for MEDLINE]
15.

Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study.

Rutkowski S, De Vleeschouwer S, Kaempgen E, Wolff JE, Kühl J, Demaerel P, Warmuth-Metz M, Flamen P, Van Calenbergh F, Plets C, Sörensen N, Opitz A, Van Gool SW.

Br J Cancer. 2004 Nov 1;91(9):1656-62.

PMID:
15477864
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Transient local response and persistent tumor control in a child with recurrent malignant glioma: treatment with combination therapy including dendritic cell therapy. Case report.

De Vleeschouwer S, Van Calenbergh F, Demaerel P, Flamen P, Rutkowski S, Kaempgen E, Wolff JE, Plets C, Sciot R, Van Gool SW.

J Neurosurg. 2004 May;100(5 Suppl Pediatrics):492-7.

PMID:
15287461
[PubMed - indexed for MEDLINE]
17.

Late-type allergy to Ultravist (iopromid).

Otto K, Kaempgen E, Dummer W, Broecker EB, Becker JC.

Allergy. 2003 Mar;58(3):261-2. No abstract available.

PMID:
12653805
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk